U.S. markets closed
  • S&P 500

    3,790.93
    +112.50 (+3.06%)
     
  • Dow 30

    30,316.32
    +825.43 (+2.80%)
     
  • Nasdaq

    11,176.41
    +360.97 (+3.34%)
     
  • Russell 2000

    1,775.77
    +66.90 (+3.91%)
     
  • Crude Oil

    86.48
    -0.04 (-0.05%)
     
  • Gold

    1,733.50
    +3.00 (+0.17%)
     
  • Silver

    21.07
    -0.03 (-0.16%)
     
  • EUR/USD

    0.9985
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    3.6170
    -0.0340 (-0.93%)
     
  • GBP/USD

    1.1457
    -0.0018 (-0.15%)
     
  • USD/JPY

    144.0100
    -0.1890 (-0.13%)
     
  • BTC-USD

    20,345.40
    +719.06 (+3.66%)
     
  • CMC Crypto 200

    460.91
    +15.47 (+3.47%)
     
  • FTSE 100

    7,086.46
    +177.70 (+2.57%)
     
  • Nikkei 225

    26,992.21
    +776.42 (+2.96%)
     

Investors Bet Ketamine Treatment Will Revolutionize Mental-Health Care

Hundreds of clinics specializing in ketamine treatment for depression and other mood disorders have popped up in the U.S. in recent years. WSJ visits one clinic, Nushama, to learn why some entrepreneurs are betting that demand for ketamine will continue to rise. Photo illustration: Laura Kammermann/WSJ